MONMOUTH JUNCTION, NJ–(Marketwired – July 10, 2014) – DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring of neurodegenerative diseases and cancer based on analysis of organ-enriched microRNA biomarker pairs in plasma, announced today that the company’s President and Chief Scientific Officer, Dr. Samuil Umansky, will be presenting at the 2014 Alzheimer’s Association International Conference in Copenhagen, Denmark.